4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000132
Chairperson & CEO sold 9,500 shares at an average $511.09 ($4,855,312)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-31 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $135.42 | $1,286,490 | 333,943 | I |
| 2026-08-31 | Sale : show line 2 in the form 10b5-1 | −599 | $507.84 | $304,198 | 333,344 | I |
| 2026-08-31 | Sale : show line 3 in the form 10b5-1 | −794 | $508.92 | $404,082 | 332,550 | I |
| 2026-08-31 | Sale : show line 4 in the form 10b5-1 | −810 | $509.84 | $412,967 | 331,740 | I |
| 2026-08-31 | Sale : show line 5 in the form 10b5-1 | −4,217 | $510.93 | $2,154,598 | 327,523 | I |
| 2026-08-31 | Sale : show line 6 in the form 10b5-1 | −1,600 | $511.75 | $818,801 | 325,923 | I |
| 2026-08-31 | Sale : show line 7 in the form 10b5-1 | −678 | $513.50 | $348,154 | 325,245 | I |
| 2026-08-31 | Sale : show line 8 in the form 10b5-1 | −762 | $514.32 | $391,913 | 324,483 | I |
| 2026-08-31 | Sale : show line 9 in the form 10b5-1 | −40 | $514.96 | $20,598 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $511.09 · $4,855,312 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-31 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option | −9,500 | 27,910 | I |
Loading xslF345X06/primarydocument.xml…